Update shared on 30 Nov 2025
Fair value Increased 10%Analysts have raised their price target for Agilent Technologies from $152.33 to $167.57, citing modestly higher expectations for revenue growth and valuation metrics as the primary reasons for the change.
What's in the News
- Agilent Technologies provided earnings guidance for fiscal Q1 2026, expecting revenue in the range of $1.79 billion to $1.82 billion, up 6% to 8% reported and 4% to 6% core. Fiscal 2026 revenue is expected between $7.3 billion and $7.4 billion, a 5% to 7% reported increase (Corporate Guidance).
- The company announced a quarterly dividend of 25.5 cents per share, payable on January 28, 2026, to shareholders of record as of January 6, 2026 (Dividend Announcement).
- Adam S. Elinoff was appointed Chief Financial Officer, effective November 17, 2025. He will replace Rodney Gonsalves, who will resume his role as Vice President, Corporate Controller, and Principal Accounting Officer (Executive Appointment).
- Agilent launched the Insight Series Alarm Resolution Systems, advanced screening technologies aimed at improving safety and efficiency at airport security checkpoints worldwide (Product Launch).
- The company released Agilent Altura Ultra Inert HPLC columns, offering higher performance and enhanced sensitivity for biotherapeutics research and quality control (Product Launch).
- Lunit and Agilent entered a nonexclusive partnership to develop AI-powered companion diagnostic solutions for greater precision in biomarker testing and drug development (Strategic Alliance).
Valuation Changes
- Consensus Analyst Price Target has risen from $152.33 to $167.57, reflecting modestly higher market expectations.
- Discount Rate increased slightly from 7.91% to 7.92%, indicating updated risk assessments.
- Revenue Growth estimate rose moderately from 6.02% to 6.24% as analysts forecast improved sales expansion.
- Net Profit Margin declined modestly from 22.38% to 22.18%, suggesting slightly lower anticipated profitability.
- Future P/E multiple increased from 29.29x to 31.35x, pointing to heightened valuation expectations for upcoming earnings.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.